CARE Hospitals hosts insurance summit to strengthen trust in healthcare
Healthcare and insurance are not parallel systems; they are interdependent pillars of patient trust
Healthcare and insurance are not parallel systems; they are interdependent pillars of patient trust
Takeda said zasocitinib was generally well tolerated, with a safety profile consistent with earlier studies
SandboxAQ will receive an upfront payment and could earn up to $200 million in milestone payments tied to preclinical, development, regulatory, and commercial achievements
Efdoralprin alfa, a recombinant human alpha-1 antitrypsin (AAT)-Fc fusion protein, showed superior efficacy to standard plasma-derived therapy in adults with AATD
USFDA determines Sun Pharma's Baska facility inspection classification as OAI
The NP resin portfolio, indicated by its UL746G-certified prefix, equips manufacturers across industries to meet increasingly stringent regulatory and performance standards
If cleared by regulators, CagriSema would become the first treatment to combine a GLP-1 receptor agonist and a long-acting amylin analogue in a single injection
This agreement will enhance Lupin’s gastroenterology portfolio and expand its presence in emerging markets
The study found BIC/LEN to be statistically non-inferior to BIKTARVY, Gilead’s current standard-of-care therapy
The funding will support the pivotal Phase 3 clinical trial of neridronate in CRPS-1
Subscribe To Our Newsletter & Stay Updated